🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the effect of canagliflozin (JNJ-284...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT01787357
Treatments Being Tested
The main aim of this study is to find out how more than one dose of TAK-279...
Status
Completed
Location
Celerion
Start Date
2024-04-29
Trial ID
NCT06258265
Treatments Being Tested
The purpose of this study is to assess the effects of single dose seltorexa...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2018-04-09
Trial ID
NCT03494907
Treatments Being Tested
The objective of this study was to evaluate the effects of cebranopadol (GR...
Status
Completed
Location
US001 Contract research organization
Start Date
2013-07-10
Trial ID
NCT03958123
The purpose of the study is look at the possible side effects of two differ...
Status
Completed
Location
Cetero Reserach
Start Date
2010-06
Trial ID
NCT02508753
Treatments Being Tested
The main aim is to see if soticlestat has any effect in the heart rate. Pa...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-10-11
Trial ID
NCT05309902
Treatments Being Tested
This study is comprised of two parts. The purpose of the first part of this...
Status
Completed
Location
Altasciences Clinical Kansas, Inc
Start Date
2022-06-22
Trial ID
NCT05478278
Treatments Being Tested
The purpose of this research study is to evaluate the effect of AZD3199 on ...
Status
Completed
Location
Research Site
Start Date
2010-11
Trial ID
NCT01222442
Treatments Being Tested
Compare the acute effect on the QT interval of MAP0004 (Dihydroergotamine M...
Status
Completed
Location
Cetero Research
Start Date
2010-08
Trial ID
NCT01191723
Treatments Being Tested
This is a two part study. Part A will determine the maximum tolerated dose ...
Status
Terminated
Location
Research Site
Start Date
2011-06
Trial ID
NCT01359618
Treatments Being Tested